Cargando…

An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions

Background: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions....

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Christopher J., Scoville, Jonathan, Ruble, James, Condie, Chad, Davis, Gary, Floyd, Candace L., Kelly, Logan, Monson, Ken, Reichert, Ethan, Sarigul, Buse, Hawryluk, Gregory W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165175/
https://www.ncbi.nlm.nih.gov/pubmed/34079515
http://dx.doi.org/10.3389/fneur.2021.667842
_version_ 1783701260562595840
author Carr, Christopher J.
Scoville, Jonathan
Ruble, James
Condie, Chad
Davis, Gary
Floyd, Candace L.
Kelly, Logan
Monson, Ken
Reichert, Ethan
Sarigul, Buse
Hawryluk, Gregory W. J.
author_facet Carr, Christopher J.
Scoville, Jonathan
Ruble, James
Condie, Chad
Davis, Gary
Floyd, Candace L.
Kelly, Logan
Monson, Ken
Reichert, Ethan
Sarigul, Buse
Hawryluk, Gregory W. J.
author_sort Carr, Christopher J.
collection PubMed
description Background: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions. Methods: We measured pH and concentration in 37 commonly-used hyperosmolar solutions, including 20 and 25% mannitol and 3, 5, 14.6, and 23.4% hypertonic saline. pH was determined digitally and with litmus paper. Concentration was determined by freezing point and vapor pressure osmometry. Salinity/specific gravity was measured with portable refractometry. Particulate matter was analyzed with filtration and light microscopy and with dynamic light scattering nephelometry. Results: pH of all solutions was below physiological range (measured range 4.13–6.80); there was no correlation between pH and solution concentration (R(2) = 0.005, p = 0.60). Mannitol (mean 5.65, sd 0.94) was less acidic than hypertonic saline (5.16, 0.60). 14/59 (24%) pH measurements and 85/111 concentration measurements were outside manufacturer standards. All 36/36 mannitol concentration measurements were outside standards vs. 48/72 (67%) hypertonic saline (p < 0.0001). All solutions examined on light microscopy contained crystalline and/or non-crystalline particulate matter up to several hundred microns in diameter. From nephelometry, particulate matter was detected in 20/22 (91%) solutions. Conclusion: We present a novel characterization of mannitol and hypertonic saline. Further research should be undertaken, including research examining development of acidosis following hyperosmolar therapy, the relevance of our findings for dose-response, and the clinical relevance of particulate matter in solution.
format Online
Article
Text
id pubmed-8165175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81651752021-06-01 An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions Carr, Christopher J. Scoville, Jonathan Ruble, James Condie, Chad Davis, Gary Floyd, Candace L. Kelly, Logan Monson, Ken Reichert, Ethan Sarigul, Buse Hawryluk, Gregory W. J. Front Neurol Neurology Background: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions. Methods: We measured pH and concentration in 37 commonly-used hyperosmolar solutions, including 20 and 25% mannitol and 3, 5, 14.6, and 23.4% hypertonic saline. pH was determined digitally and with litmus paper. Concentration was determined by freezing point and vapor pressure osmometry. Salinity/specific gravity was measured with portable refractometry. Particulate matter was analyzed with filtration and light microscopy and with dynamic light scattering nephelometry. Results: pH of all solutions was below physiological range (measured range 4.13–6.80); there was no correlation between pH and solution concentration (R(2) = 0.005, p = 0.60). Mannitol (mean 5.65, sd 0.94) was less acidic than hypertonic saline (5.16, 0.60). 14/59 (24%) pH measurements and 85/111 concentration measurements were outside manufacturer standards. All 36/36 mannitol concentration measurements were outside standards vs. 48/72 (67%) hypertonic saline (p < 0.0001). All solutions examined on light microscopy contained crystalline and/or non-crystalline particulate matter up to several hundred microns in diameter. From nephelometry, particulate matter was detected in 20/22 (91%) solutions. Conclusion: We present a novel characterization of mannitol and hypertonic saline. Further research should be undertaken, including research examining development of acidosis following hyperosmolar therapy, the relevance of our findings for dose-response, and the clinical relevance of particulate matter in solution. Frontiers Media S.A. 2021-05-17 /pmc/articles/PMC8165175/ /pubmed/34079515 http://dx.doi.org/10.3389/fneur.2021.667842 Text en Copyright © 2021 Carr, Scoville, Ruble, Condie, Davis, Floyd, Kelly, Monson, Reichert, Sarigul and Hawryluk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Carr, Christopher J.
Scoville, Jonathan
Ruble, James
Condie, Chad
Davis, Gary
Floyd, Candace L.
Kelly, Logan
Monson, Ken
Reichert, Ethan
Sarigul, Buse
Hawryluk, Gregory W. J.
An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_full An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_fullStr An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_full_unstemmed An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_short An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_sort audit and comparison of ph, measured concentration, and particulate matter in mannitol and hypertonic saline solutions
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165175/
https://www.ncbi.nlm.nih.gov/pubmed/34079515
http://dx.doi.org/10.3389/fneur.2021.667842
work_keys_str_mv AT carrchristopherj anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT scovillejonathan anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT rublejames anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT condiechad anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT davisgary anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT floydcandacel anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT kellylogan anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT monsonken anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT reichertethan anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT sarigulbuse anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT hawrylukgregorywj anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT carrchristopherj auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT scovillejonathan auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT rublejames auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT condiechad auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT davisgary auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT floydcandacel auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT kellylogan auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT monsonken auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT reichertethan auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT sarigulbuse auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT hawrylukgregorywj auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions